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Splenic Rupture in a COVID-19 Patient – A Case Report 
Anna C. Crowley,1 Raul R. Magadia,2 Arianna B. Lanpher.3  
Abstract 
Background: It is well known that the Coronavirus disease 2019 (COVID-19) causes coagulation changes, requiring frequent monitoring for potential sequelae 
such as myocardial infarction and stroke. Non-traumatic splenic rupture is a rare and poorly understood occurrence in the clinical setting. Possible causes 
of nontraumatic splenic rupture include neoplasm, infection, inflammatory disease, iatrogenic and mechanical causes. Furthermore, increased intrasplenic 
tension, increased abdominal pressure, and thrombotic vascular occlusion are possible mechanisms. The Case: We report a case of splenic rupture in a 
COVID-19 patient. Our patient was a 52-year-old black man, presenting with diarrhea and moderate dyspnea, who was found to be COVID-19 positive. He 
had a past medical history significant for end-stage renal disease, chronic anemia, and aortic valve replacement. In an otherwise uneventful, 7-day hospital 
course, the patient’s stay abruptly resulted in a nontraumatic splenic rupture and demise. In this report, we have evaluated the likelihood of COVID-19 
causing splenic rupture in a patient with no prior splenic disease. Conclusion: This case highlights the possibility of splenic rupture in otherwise normally 
recovering COVID-19 patients, particularly in the presence of comorbid conditions of renal failure and anticoagulation, with increased abdominal pressure 
during routine defecation. This information may assist in furthering the pathophysiology of COVID-19 and its life-threatening complications. In patients 
with COVID-19, non-traumatic splenic rupture should be considered as one of the differential diagnoses in patients who present with abdominal pain and 
early recognition of the same, owing to a high index of suspicion, can be lifesaving. 
 




While the Coronavirus disease 2019 (COVID-19) is known to present with 
significant pulmonary and cardiac manifestations, other systemic 
complications and interactions with pre-existing pathology are being 
recognized.1 As the pandemic has evolved, hypercoagulability and 
microvascular changes are becoming more prevalent causes of 
mortality.2 Here, we describe a case of nontraumatic splenic rupture in 
a COVID-19 patient being treated with anticoagulants and routine 
hemodialysis. Atraumatic splenic rupture is exceedingly rare and a 
potentially fatal condition. Causes of atraumatic splenic rupture include 
neoplasms, infection, iatrogenic, mechanical and inflammatory states.3 
This case illustrates how interactions with chronic renal disease and 
anticoagulation use may be important considerations in the treatment 
of complicated COVID-19 patients.  
 
The Case 
History of Present Illness 
A 52-year-old Black male presented to the Emergency Department with 
a chief complaint of diarrhea for 1 day, followed by moderate dyspnea. 
At the time of admission, the BUN/Cr ratio was 44/11.3, and on 
admission, the SARS-CoV-2 antigen by IFA (in-house, Sofia) was positive. 
The patient was afebrile (36.9 °C), and the oxygen saturation was 100% 
on room air.  
 
Past Medical History 
He had a past medical history of hypertension, hepatitis B (2006), end-
stage renal disease (2005), hyperlipidemia, severe anemia (2008), and 
aortic valve replacement (2019). Current medications included warfarin 
(10mg daily, in addition to supplemental 5mg on M/W/F) due to past 
mechanical aortic valve replacement. The patient’s goal  INR  was  2.5- 
 
 
3.5. The patient had a history of hemodialysis noncompliance and often 
did not attend the recommended treatments. From laboratory data in 
2019, the patient’s average BUN/Cr was 34.2/6.5, respectively. Patient 
denied any recent travel. He did not have any personal or family history 
of leukemia, lymphoma, coagulopathies, DVT/PE, auto-immune 
pathology, or other neoplasms.  
 
Investigations  
Laboratory results on admission were significant for pancytopenia, 
elevated inflammatory markers, and elevated coagulation studies. From 
laboratory data in 2019, the patient had a history of leukopenia, 
anemia, platelet count of 160.7 (103/L), and an average Hgb/Hct of 
8.2/25.6 (g/dL/%), respectively.  Physical exam revealed normal lung 
sounds, no hepatosplenomegaly, or lymphadenopathy. Prior to this 
current admission, the patient was evaluated for further renal disease 
progression in December 2018. There was no evidence of splenic injury 
or splenomegaly on the 2018 abdominal CT.  The patient’s pancytopenia 
Highlights: 
 Presentation of a unique case of COVID-19 complicated by non-
traumatic splenic rupture. 
 Diagnostic dilemma of conflicting coagulation studies in a COVID-19 
patient with chronic renal failure requiring hemodialysis and valve 
replacement requiring warfarin therapy, leading to splenic rupture, a 
complication that is associated with hypocoagulable state. 
 Highlights possibility of fatal splenic rupture in COVID-19 patients with 
comorbid renal disease and complex coagulation states, reminding 
clinicians that rapid diagnosis and surgical correction can be life-
saving. 
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was evaluated during his stay at the hospital; both nutritional and viral 
etiologies, as well as bone marrow failure, were ruled out with appropriate 
investigations, as shown in Table 1. Peripheral smear was unremarkable. 
 
Hospital Course: On the second day of admission, the patient received 
dialysis, and over the next six days underwent a total of three 
hemodialysis treatments coupled with three separate packed RBC 
transfusions because of his severe anemia. His chest radiograph 
remained clear and diarrhea subsided by Day 2. Due to the belief that 
the patient’s symptoms were due to COVID-19 initially, no abdominal 
imaging was performed on admission. On Day 5, the INR increased to 
5.13 and remained above the therapeutic range (2.5-3.5) for the 
remainder of his hospital course. After the patient’s increase in 
coagulation studies, his regular warfarin treatment regimen (10mg daily, 
in addition to supplemental 5mg on M/W/F) was discontinued on day 6.  
 
On Day 8, when attempting defecation, the patient felt a “pop” and 
developed tearing and burning LLQ flank pain at 8:00. This bowel 
movement was blood-tinged and loose. His abdominal pain progressed 
throughout the day, and at 16:00, the internist’s physical examination 
revealed a firm abdomen with no rebound tenderness.  CT scan of the 
abdomen was compatible with acute splenic hemorrhage. Before 
emergency splenectomy could be performed, the patient became 
hypotensive, developed cardiac arrest at 18:55, and expired at 19:12.  
 
The abdominal CT detected a large amount of heterogenous material 
surrounding the spleen with small to moderate amount of free fluid 
around the spleen, compatible with acute splenic hemorrhage, as 
shown in Figure 1. Due to the abrupt onset of acute intra-abdominal 
hemorrhage, the patient died prior to splenectomy or other life-saving 
interventions. No autopsy was performed.  
 




Legend: Impression Per Radiology: 1. Large amount of heterogenous material 
surrounding the spleen with small to moderate amount of free fluid in the abdomen 
compatible with acute splenic hemorrhage. 2. Renal findings compatible with 
autosomal dominant polycystic kidney disease. 3. Small bilateral pleural effusions, 
greater on the left. 4. Atherosclerosis 
 
Throughout the patient’s stay, he received the standard in-house 
COVID-19 treatment, including five days of Ascorbic acid (50 mL 
2000mg/4 mL IV), Thiamine HCl (2mL 200 mg/2 mL IV), and Zinc Sulfate 
(20 mg oral QD), along with his continued warfarin anticoagulation as 
previously prescribed until its discontinuation on Day 6. 
 
Discussion 
We believe this case of non-traumatic splenic rupture in a COVID-19 
patient was caused by interactions from COVID-19-related coagulation 
changes.  Based on recent data, COVID-19 has been shown to cause 
both hypercoagulable and hyperfibrinolyic states in patients.2 Because 
our patient was on chronic warfarin therapy and reached 
supratherapeutic levels during hospital days 5-8, we believe the effects 
of COVID-19 affected our patient’s coagulability and possibly led to his 
hemorrhagic state and splenic rupture. 
 
While the exact etiology of nontraumatic splenic rupture is not fully 
understood, three possible mechanisms could explain this patient’s 
unfortunate clinical course: increased intrasplenic tension, increased 
abdominal pressure, and altered coagulation.4 We believe the 
supratherapeutic warfarin levels and hyperfibrinolytic state caused by 
COVID-19 led to our patient’s altered coagulation studies. The process 
of defecation is a known inciting event for splenic rupture due to the 
rising intrabdominal pressure and stretching of the splenocolic ligament 
causing rupture of pre-existing subcapsular hematoma. While the 
patient had no evidence of pre-existing splenic hematoma or 
splenomegaly, we believe this was the chief inciting event leading to 
splenic rupture.5 
 
It is relevant to eliminate the other causes of nontraumatic splenic 
rupture. Because our patient did not receive an autopsy following his 
death, we cannot be certain that our patient did not have an underlying 
primary splenic neoplasm (i.e., splenic marginal zone lymphoma) or 
primary myelofibrosis. However, these etiologies are extraordinarily 
rare.6 Our patient did not present with any clinical or laboratory findings 
suggestive of an underlying hematological malignancy, and there was 
no hepatosplenomegaly, enlarged lymph nodes, or systemic B 
symptoms.  Mature B- or T-cell leukemias are unlikely because the 
patient’s lymphocyte count was within the normal range. Hairy cell 
leukemia can be ruled out because peripheral blood smear typically 
reveals a pancytopenia with monocytopenia.  Primary myelofibrosis 
typically presents with an enlarged spleen and liver with tear drop cells 
on blood smear, which was not detected in our patient. Epstein Barr 
Virus and cytomegalovirus were not suspected due to the absence of 
atypical lymphocytes and leukocytosis.  
 
Even though microvascular changes, coagulation changes, and 
defecation can be regarded as the principal causes of splenic rupture 
in this case, the consequences of repetitive hemodialysis from chronic 
renal disease cannot be overlooked. This is a rare reported complication 
of hemodialysis, and its exact incidence is not known. However, in a 
previous study of nontraumatic splenic rupture in a hemodialyzed 
patient, important risk factors included the use of anticoagulants during 
hemodialysis, uremic coagulopathy, susceptibility to infections, and 
impaired immune function. These risk factors can occur as long-term 
complications of hemodialysis, but they are also complications of 
severe coronavirus infection, which paradoxically is associated with 
coagulation changes.7 The exact etiology and pathogenesis cannot be 
confirmed due to the lack of an autopsy, and because of the extremely 
low incidence of splenic rupture due to hemodialysis, and the absence 
of known risk factors in our patient (e.g., infectious mononucleosis, 
hematologic disease, splenomegaly, neoplasm). Therefore, we believe COVID-
19 infection was a contributing cause of splenic rupture in our patient. 
 
There have been other recently reported cases of nontraumatic splenic 
rupture in the setting of COVID-19.  Research demonstrates that COVID-
19 has a direct effect on the body’s secondary lymph tissue.  Following 
these studies, there is further reason to suspect the virus has the 
potential to have a direct effect on the spleen by causing “lymphoid 
follicle attrition and nodular atrophy in addition to microvascular 
thrombosis and necrosis,” as stated in a case report by Shaukat and 
colleagues.8  
 
In monitoring COVID-19 progression, clinicians monitor inflammatory 
markers, such as C-reactive protein (CRP), lactate dehydrogenase (LDH), 
ferritin, and lymphocytes. As shown in Table 1, several other laboratory 
values are now closely monitored to evaluate the coagulation changes 
related to the COVID-19 pathogenesis including d-dimer, fibrinogen, 
prothrombin time, partial thromboplastin time, platelet count, and 
other specific quantifications such as calcium.9 Although the 
mechanism is still unknown, elevated coagulation markers support 
studies documenting many critically ill COVID-19 patients who suffer 
from a thrombotic microvascular event.10 Studies have suggested that 
in the setting of COVID-19, symptoms such as abdominal pain may be 
an indication for abdominal CT scan on admission and frequent 
monitoring throughout the patient’s disease progression. In a reported 
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Table 1. Inpatient laboratory values. 
 
Test Ref. Range Day 0 D1 D2 D3 D4 D5 D6 D7 
WBC (103/L) 4.5-10.4 1.5 1.6 1.7 1.8 2.8 3.5 5.2 5.4 
RBC (106/L) 3.7-5.3 2.41 2.37 2.11 2.29 2.10 1.64 2.04 1.91 
Hgb(g/dL)/HCT (%) 11.0-16.0/35.0-47.0 7.8/23.5 7.4/22.9 6.6/20.8 6.9/22.2 6.5/20.4 5.2/16.5 6.5/19.9 6.0/18.2 
Platelet (103/L) 140-440 54 62 60 59 76 68 72 69 
INR  2.93 -- 2.24 2.22 2.84 5.13 4.65 4.73 
PT (s) 9.8-11.6 29.8 -- 23.1 22.9 28.9 50.8 46.2 47 
aPTT (s) 23.1-31.6 56.6 --       
AST (unit/L) 2-33 24  
  
    
ALT (unit/L) 13-61 12        
Albumin (gm/dL) 3.4-5 2.7        
Ferritin (ng/mL) 8.0-252.0 2184.6 -- 
  
    
CRP (mg/L) 0.0-3.0 24.5 -- 
  
    
Procalcitonin (ng/mL) <0.10 0.52 --       
Sed Rate (mm/h) 0-30 53 --       
D-dimer 0.19-0.5 2.92 --       
LDH (unit/L) 87-241 360 -- 
  
    
BUN/Cr 7-18/0.6-1.3 44/11.3 -- 
  
    
Lymphocyte (%)  25.5 43.0 36.5 32.6 27.3 25.1 22.9 16.5 
Monocyte (%)  9.4 13.3 17.1 11.4 9.1 13.6  12.9 11.9 
patient had vague abdominal symptoms and subsequent signs of 
decompensation. Urgent laparotomy was performed, revealed 
atraumatic splenic rupture, and splenectomy was performed. 
Fortunately, the acuity of these physicians’ actions were able to save 
the patient’s life.11 
 
Due to the multisystem involvement of COVID-19, coagulation studies 
are becoming increasingly relevant in that the virus can cause both 
hypercoagulable and hemorrhagic changes. We are assuming that our 
patient’s hyperfibrinolytic state led to his splenic hemorrhage. While 
the coronavirus remains a heavily studied topic both microbiologically 
and clinically, it is pertinent that clinicians grow more cognizant of 
emerging complications related to COVID-19. This case highlights the 
importance of monitoring coagulation studies while maintaining a high 
index of suspicion for rare but life-threatening intra-abdominal 
complications. In patients with COVID-19, non-traumatic splenic rupture 
should be considered as one of the differential diagnoses in patients 
who present with abdominal pain and early recognition of the same, 
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